Setting Our Sights on Infectious Diseases

Simple item page
dc.contributor.authorAmewu, R.K.
dc.contributor.authorDe Rycker, M.
dc.contributor.authorHorn, D.
dc.contributor.authorAldridge, B.
dc.contributor.authorBarry, C.E.
dc.contributor.authorBuckner, F.S.
dc.contributor.authorCook, S.
dc.contributor.authorFerguson, M.A.J.
dc.contributor.authorGobeau, N.
dc.contributor.authorHerrmann, J.
dc.contributor.authorHerrling, P.
dc.contributor.authorHope, W.
dc.contributor.authorKeiser, J.
dc.contributor.authorLafuente-Monasterio, M.J.
dc.contributor.authorLeeson, P.D.
dc.contributor.authorLeroy, D.
dc.contributor.authorManjunatha, U.H.
dc.contributor.authorMiles, T.J.
dc.contributor.authorMizrahi, V.
dc.contributor.authorMoshynets, O.
dc.contributor.authorNiles, J.
dc.contributor.authorOverington, J.P.
dc.contributor.authorPottage, J.
dc.contributor.authorRao, S.P.S.
dc.contributor.authorRead, K.D.
dc.contributor.authorRibeiro, I.
dc.contributor.authorSilver, L.L.
dc.contributor.authorSouthern, J.
dc.contributor.authorSpangenberg, T.
dc.contributor.authorSundar, S.
dc.contributor.authorTaylor, C.
dc.contributor.authorVan Voorhis, W.
dc.contributor.authorWhite, N.J.
dc.contributor.authorWyllie, S.
dc.contributor.authorWyatt, P.G.
dc.contributor.authorGilbert, I.H.
dc.date.accessioned2020-01-31T08:56:34Z
dc.date.available2020-01-31T08:56:34Z
dc.date.issued2019-12-06
dc.descriptionResearch Articleen_US
dc.description.abstractIn May 2019, the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee, UK, held an international conference with the aim of discussing some key questions around discovering new medicines for infectious diseases and a particular focus on diseases affecting Low and Middle Income Countries. There is an urgent need for new drugs to treat most infectious diseases. We were keen to see if there were lessons that we could learn across different disease areas and between the preclinical and clinical phases with the aim of exploring how we can improve and speed up the drug discovery, translational, and clinical development processes. We started with an introductory session on the current situation and then worked backward from clinical development to combination therapy, pharmacokinetic/pharmacodynamic (PK/PD) studies, drug discovery pathways, and new starting points and targets. This Viewpoint aims to capture some of the learningsen_US
dc.identifier.otherDOI: 10.1021/acsinfecdis.9b00371
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/34714
dc.language.isoenen_US
dc.publisherACS Infectious Diseasesen_US
dc.relation.ispartofseries6;2020
dc.subjectWellcome Centre for Anti-Infectives Research (WCAIR)en_US
dc.subjectmedicinesen_US
dc.subjectinfectious diseasesen_US
dc.subjectLow and Middle Income Countriesen_US
dc.titleSetting Our Sights on Infectious Diseasesen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Setting-Our-Sights-on-Infectious-DiseasesACS-Infectious-Diseases.pdf
Size:
624.72 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Chemistry